您的位置: 首页 > 农业专利 > 详情页

CARBOXAMIDE COMPOUNDS
专利权人:
发明人:
KLING, ANDREAS,安德烈 克林,安德烈 克林,HORNBERGER, WILFRIED,威尔菲得 霍恩博格,威爾菲得 霍恩博格,MACK, HELMUT,海姆特 麦克,海姆特 麥克,MOELLER, ACHIM,亚钦 莫勒,亞欽 莫勒,VOGG, BARBARA,芭芭拉 佛格,芭芭拉 佛格,BACKFISCH, GISELA,吉斯拉 贝克费斯可,吉斯拉 貝克費斯可,BEYERBACH,
申请号:
TW097151007
公开号:
TWI453019B
申请日:
2008.12.26
申请国别(地区):
TW
年份:
2014
代理人:
摘要:
The present invention relates to novel carboxamide compounds of the formula I and their use for the manufacture of a medicament. The carboxamide compounds are prodrugs of inhibitors of calpain (calcium dependant cysteine proteases). The invention therefore also relates to the use of these carboxarnide compounds for treating a disorder associated with an elevated calpain activity.R1 is C1-C10-alkyl, C2-C10-alkenyl, C2-C10-alkynyl, C3-C7-cycloalkyl, C3-C7-cycloalkyl-C1-C4-alkyl, aryl, hetaryl, aryl-C1-C6-alkyl, aryl-C2-C6-alkenyl, hetaryl-C1-C4-alkyl or hetaryl-C2-C6-alkenyl,R2 is C3-C7-cycloalkyl, C3-C7-cycloalkyl-C1-C4-alkyl, aryl, O-aryl, O-CH2-aryl, hetaryl, aryl-C1-C6-alkyl, aryl-C2-C6-alkenyl, hetaryl-C1-C4-alkyl or hetaryl-C2-C6-alkenyl,R3aand R3btogether form a moiety S-AlK-S, O-AlK-S or O-Alk-O, wherein Alk is linear C2-C5-alkandiyl, which may be unsubstituted or substituted with 1, 2, 3 or 4 radicals selected from C1-C4-alkyl or halogenX is a radical of the formulae C(=O)-O-Rx1, C(=O)-NRx2Rx3, C(=O)-N(Rx4)-(C1-C6-alkylene)-NRx2Rx3or C(=O)-N(Rx4)NRx2Rx3,n is 0, 1 or 2,one of the variables Y1, Y2, Y3or Y4is a nitrogen atom, and the remaining variables Y1, Y2, Y3or Y4are CHRy is e.g. OH, SH, halogen, NO2, NH2, CN, CF3, CHF2, CH2F, O-CF3, O-CHF2, O-CH2F, COOH, OCH2COOH, C1-C6-alkyl, C1-C6-alkoxy, C1-C6-alkoxy-C1-C4-alkyl, C1-C6-alkylthio etc.W is a radical of the formulae W1 or W2 which is linked via nitrogen:in which * means the linkage to the 6-membered heteroaromatic ring, and # means the linkage to R2, m is 0, 1 or 2, and Rwis e.g. OH, SH, halogen, NO2, NH2, CN, CF3, CHF2, CH2F, O-CF3, O-CHF2, O-CH2F, COOH, OCH2COOH.本發明係關於新穎式I甲醯胺化合物,及其關於藥劑製造之用途。該甲醯胺化合物為鈣蛋白酶(鈣依賴性半胱胺酸蛋白酶)抑制劑之前體藥物。本發明因此亦關於利用此等甲醯胺化合物以治療與高鈣蛋白酶活性有關聯之病症。R1 為C1-C10-烷基、C2-C10-烯基、C2-C10-炔基、C3-C7-環烷基、C3-C7-環烷基-C1-C4-烷基、芳基、雜芳基、芳基-C1-C6-烷基、芳基-C2-C6-烯基、雜芳基-C1-C4-烷基或雜芳基-C2-C6-烯基,R2 為C3-C7-環烷基、C3-C7-環烷基-C1-C4-烷基、芳基、O-芳基、O-CH2-芳基、雜芳基、芳基-C1-C6-烷基、芳基-C2-C6-烯基、雜芳基-C1-C4-烷基或雜芳基-C2-C6-烯基,R3a與R3b一起形成部份基團S-Alk-S、O-
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充